• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number VAMF3636C200TE
Device Problem Difficult or Delayed Positioning (1157)
Patient Problems Intimal Dissection (1333); Vascular Dissection (3160)
Event Date 10/13/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
A valiant captivia stent graft was attempted to be implanted in the endovascular treatment of a 32 mm thoracic aortic aneurysm.It was reported that during the index procedure, the main body could not be entered during the operation, and a dissection of the femoral artery occurred.Ballooning was performed and a 8*10 stent was placed outside the iliac stenosis, however the main body still could not be entered.Ballooning was performed again and the incision was raised 4-5cm upward, it still could not be entered.An attempt to double guide wire was used to stretch the artery at the incision, with no success.It was stated that the stenosis on the other side was more visible, and the angiography of the approach showed more distorted than the right side.The physician then decided to abort the procedure.No cause of the event was reported.No additional clinical sequelae were reported and the patient will be monitored.
 
Manufacturer Narrative
Product analysis the device returned with the external slider and tip capture release handle in the home position.Scratches and slight lifting of the graft cover material was observed.There was no further deformation evident to the device.The reported positioning difficulties were confirmed through analysis.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
B:5 additional information received: the cause of the dissection was reportedly due to atherosclerosis.It was confirmed that the dissection was treated and is now resolved.A:4 updated if information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT CAPTIVIA - FF
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key10769734
MDR Text Key214104305
Report Number9612164-2020-04185
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup,Followup
Report Date 12/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/06/2021
Device Model NumberVAMF3636C200TE
Device Catalogue NumberVAMF3636C200TE
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/10/2020
Initial Date Manufacturer Received 10/13/2020
Initial Date FDA Received11/02/2020
Supplement Dates Manufacturer Received11/04/2020
12/10/2020
Supplement Dates FDA Received11/27/2020
12/22/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient Weight65
-
-